Single or Repeat Dose of G03-52-01 in Adult Subjects

Clinical trial NCT05348993 · COMPLETED

Trial details

NCT number: NCT05348993
Sponsor: U.S. Army Medical Research and Development Command
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Healthy Botulinum Toxin

Start date: 2022-06-15
Primary completion: 2025-02-18
Enrollment: 622

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.